John Stewart, Director of Specialised Commissioning at NHS England said: “For babies born very prematurely, the risk of ...

The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...

The FDA appears ready to reconsider its restrictions on therapeutic use of MDMA, ibogaine, and other drugs, but some worry ...

Australian births with continuity of obstetric-led care in private hospitals have significantly fewer adverse outcomes and cost less than births in public hospitals with care by multiple health ...

Ketamine and the use of other psychedelics for mental health disorders has become a more mainstream topic over the past few ...

Carlos Alcaraz is a #Wimbledon finalist for the THIRD YEAR IN A ROW 😮 The two-time defending champion defeats Taylor Fritz 6 ...

An expert committee set up to probe the recent surge in heart attack-related deaths in Karnataka's Hassan district has ...

AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...

Admissions are currently open. For more details and to apply, interested candidates can visit the official IIT Delhi ...

--Celcuity Inc., a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced preliminary clinical data for gedatolisib in two early phase ...

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting ...

BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025 Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4 ...